![Harry Relouw](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Harry Relouw
Director Ejecutivo en Basic Pharma Holding BV .
Perfil
Harry Relouw is currently the Chairman-Management Board, CFO & General Manager at Basic Pharma Holding BV since 2012.
He is also the Chief Financial Officer & Director at Matisse Pharmaceuticals BV.
In the past, he worked as the Director Finance & Control at Prosensa Holding NV from 2009 to 2012 and as the Chief Financial Officer at Rhein Biotech NV from 1999 to 2003.
Cargos activos de Harry Relouw
Empresas | Cargo | Inicio |
---|---|---|
Basic Pharma Holding BV
![]() Basic Pharma Holding BV Pharmaceuticals: OtherHealth Technology Basic Pharma Holding BV develops, manufactures, and distributes pharmaceutical products and forms. It offers registered and investigational medicinal products and products by route of administration. It also provides process and product development, quality assurance, regulatory, pharmacovigilance, clinical trial, and laboratory services. The company was founded by Bob Kool and Jacques Havermans in 2003 and is headquartered in Geleen, the Netherlands. | Director Ejecutivo | 01/01/2012 |
Matisse Pharmaceuticals BV
![]() Matisse Pharmaceuticals BV BiotechnologyHealth Technology Matisse Pharmaceuticals BV engages in the development of therapeutic product for the treatment of sepsis. It offers The company was founded in 2014 and is headquartered in Geleen the Netherlands. | Director Financiero/CFO | - |
Antiguos cargos conocidos de Harry Relouw.
Empresas | Cargo | Fin |
---|---|---|
PROSENSA HOLDING NV | Director Financiero/CFO | 01/01/2012 |
Rhein Biotech NV
![]() Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands. | Director Financiero/CFO | 01/01/2003 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Rhein Biotech NV
![]() Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands. | Commercial Services |
Prosensa Holding NV
![]() Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Basic Pharma Holding BV
![]() Basic Pharma Holding BV Pharmaceuticals: OtherHealth Technology Basic Pharma Holding BV develops, manufactures, and distributes pharmaceutical products and forms. It offers registered and investigational medicinal products and products by route of administration. It also provides process and product development, quality assurance, regulatory, pharmacovigilance, clinical trial, and laboratory services. The company was founded by Bob Kool and Jacques Havermans in 2003 and is headquartered in Geleen, the Netherlands. | Health Technology |
Matisse Pharmaceuticals BV
![]() Matisse Pharmaceuticals BV BiotechnologyHealth Technology Matisse Pharmaceuticals BV engages in the development of therapeutic product for the treatment of sepsis. It offers The company was founded in 2014 and is headquartered in Geleen the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Harry Relouw